Stanisz et al. demonstrated that carriers of the BRCA1 and BRCA2 mutations with high neuroticism scores had decreased quality of life (QoL), especially in the domains of low mood, anxiety, and sleep disorders. This evidence concerns the gene BRCA1 and sleep disorder.